Table 1. Clinical and Laboratory Characteristics of Participants Infected with M.genitalium.
| Male n = 161 (%) | Female n = 30 (%) | |
| Specimens in which M.genitalium was detected | ||
| First pass urine | 155 (96) | 3 (10) |
| Urethral swab | 2 (1) | - |
| Rectal swab | 4 (3) | - |
| Cervical swab | - | 23 (77) |
| High vaginal swab | - | 4 (13) |
| Clinical characteristics | ||
| Urethral discharge | ||
| no | 35 (22) | |
| yes | 126 (78) | |
| Dysuria | ||
| no | 71 (44) | - |
| yes | 90 (56) | 5 (17) |
| Urethral Irritation/itch | ||
| no | 116 (72) | |
| yes | 45 (28) | |
| Meatal Inflammation | ||
| no | 138 (86) | |
| yes | 23 (14) | |
| Vaginal Discharge | ||
| no | - | 15 (50) |
| yes | - | 15 (50) |
| Dyspareunia | ||
| no | - | 25 (83) |
| yes | - | 5 (17) |
| Lower Abdominal Pain | ||
| no | - | 23 (77) |
| yes | - | 7 (23) |
| Abnormal vaginal bleeding | ||
| no | - | 25 (83) |
| yes | - | 5 (17) |
| Mucopurulent cervicitis | ||
| no | - | 23 (77) |
| yes | - | 7 (23) |
| Cervical contact bleeding | ||
| no | - | 25 (83) |
| yes | - | 5 (17) |
| Cervical or adnexal tenderness | ||
| no | - | 21 (70) |
| yes | - | 9 (30) |
| Genital coinfections with M.genitalium | ||
| Urethral M.genitalium (n = 157) * | Cervicovaginal M.genitalium (n = 30) | |
| C.trachomatis (urethra/urine) | ||
| Not detected | 141 (90) | - |
| Detected | 15 (10) | - |
| C.trachomatis (rectal)# | ||
| Not detected | 24 (92) | - |
| Detected | 2 (8) | - |
| C.trachomatis (cervix/vagina) | ||
| Not detected | - | 29 (97) |
| Detected | - | 1 (3) |
| N.gonorrhoeae (urethra) | ||
| Not detected | 141 (91) | - |
| Detected | 14 (9) | - |
| N.gonorrhoeae (rectal) | ||
| Not detected | 26 (93) | - |
| Detected | 2 (7) | - |
| N.gonorrhoeae (throat) | ||
| Not detected | 27 (93) | - |
| Detected | 2 (7) | - |
| Bacterial vaginosis | ||
| Not detected | - | 15 (56) |
| Detected | 12 (44) | |
*
There were no rectal coinfections. #Note rectal and pharyngeal STI screening indicated in MSM (n = 48) only and not performed in all cases. Testing for Chlamydia trachomatis was by strand-displacement-amplification (ProbeTec-ETCT-Amplified DNA-Assay, Becton Dickinson, MD, USA). Culture for Neisseria gonorrhoeae was performed using modified-Thayer-Martin medium. Vaginal smears assessed for bacterial vaginosis according to the Nugent method.